Treatment Centers
Calgary Cutaneous Lymphoma Program
Calgary, AB, Canada
Treatment Centers and Clinical Trials
You can restrict your search to only Treatment Centers or only Clinical Trials by checking the Treatment Center or Clinical Trial checkbox under TYPE. Use the Zoom-In (+ sign on the lower right of the map) to enlarge the map area to find your preferred location. To search for a Treatment Center or Clinical Trial, click on the red map pin for the name of the facility. Click on the name of the facility for more details.
Location
Treatments/Services
Type
Treatment Centers
OhioHealth Physician Group - Hematology/Oncology
Columbus, OH, United States
Treatment Centers
ROCHESTER SKIN LYMPHOMA MEDICAL GROUP, PLLC
Fairport, NY, United States
Treatment Centers
Rush University Medical Center
Chicago, IL, United States
Treatment Centers
The University of Kansas Hospital
Kansas City, KS, United States
Treatment Centers
The Warren Alpert Medical School of Brown University, Department of Dermatology
Providence, RI, United States
Treatment Centers
Seattle Cancer Care Alliance
Seattle, WA, United States
Treatment Centers
Tulane University School of Medicine
New Orleans, LA, United States
Treatment Centers
University Dermatology Consultants, Inc.
Cincinnati, OH, United States
Treatment Centers
University Hospitals of Cleveland
Cleveland, OH, United States
Treatment Centers
University of Alabama Medical Center
Birmingham, AL, United States
Treatment Centers
University of California, San Francisco
San Francisco, CA, United States
Treatment Centers
University of Iowa Hospitals & Clinics
Iowa City, IA, United States
Treatment Centers
University of North Carolina Medical Center
Chapel Hill, NC, United States
Treatment Centers
University of Pittsburgh Medical Center
Pittsburgh, PA, United States
Treatment Centers
University of Rochester - Wilmot Cancer Institute
Rochester, NY, United States
Treatment Centers
University of Texas Southwestern Medical Center
Dallas, TX, United States
Treatment Centers
University of Virginia-Emily Couric Clinical Cancer Center
Charlottesville, VA, United States
Treatment Centers
University of Wisconsin - Madison
Madison, WI, United States
Treatment Centers
Vanderbilt University Medical Center
Nashville, TN, United States
Treatment Centers
Wake Forest Baptist Health
Winston-Salem, NC, United States
Treatment Centers
Winship Cancer Institute - Emory University
Atlanta, GA, United States
Treatment Centers
Mayo Clinic - Arizona Campus
Scottsdale, AZ, United States
Treatment Centers
Cleveland Clinic
Cleveland, OH, United States
Treatment Centers
Clinical Cancer Center, Froedtert Hospital
Milwaukee, WI, United States
Treatment Centers
Saint Louis University Cancer Center
St Louis, MO, United States
Treatment Centers
Washington University Medical Center - Siteman Cancer Center
St Louis, MO, United States
Treatment Centers
The Dermatology Clinic at University of Minnesota
Minneapolis, MN, United States
Treatment Centers
Henry Ford Medical Center - Cutaneous T-cell Lymphoma Clinic
Detroit, MI, United States
Treatment Centers
University of Michigan Medical Center
Ann Arbor, MI, United States
Treatment Centers
Northwestern Medicine
Chicago, IL, United States
Treatment Centers
University of Chicago
Chicago, IL, United States
Treatment Centers
Yale University School of Medicine
New Haven, CT, United States
Treatment Centers
Penn Cutaneous Lymphoma Program
Philadelphia, PA, United States
Treatment Centers
Jefferson Cutaneous Lymphoma Clinic
Philadelphia, PA, United States
Treatment Centers
Boston Medical Center - Cutaneous Oncology Program
Boston, MA, United States
Treatment Centers
Center for Cutaneous Oncology at Dana Farber/Brigham and Women's Cancer Center
Boston, MA, United States
Treatment Centers
Beth Israel Medical Center
Boston, MA, United States
Treatment Centers
Massachusetts General Hospital Cancer Center
Boston, MA, United States
Treatment Centers
Virginia Commonwealth University Medical Center
Richmond, VA, United States
Treatment Centers
INOVA Melanoma and Skin Oncology Center
Fairfax, VA, United States
Treatment Centers
Dartmouth-Hitchcock Norris Cotton Cancer Center
Lebanon, NH, United States
Treatment Centers
Columbia University Irving Medical Center - Cutaneous Lymphoma Center
New York, NY, United States
Treatment Centers
NYU Grossman School of Medicine
New York, NY, United States
Treatment Centers
University of Texas MD Anderson Cancer Center
Houston, TX, United States
Treatment Centers
Moffitt Cancer Center
Tampa, FL, United States
Treatment Centers
Cleveland Clinic - Indian River Hospital
Vero Beach, FL, United States
Treatment Centers
Miami Cancer Institute BHSF
Miami, FL, United States
Treatment Centers
Levine Cancer Institute
Charlotte, NC, United States
Treatment Centers
Duke Cutaneous T-Cell Lymphoma Clinic and Research Center
Durham, NC, United States
Treatment Centers
UCHealth - University of Colorado Cancer Center - Anschutz
Aurora, CO, United States
Treatment Centers
Huntsman Cancer Institute
Salt Lake City, UT, United States
Treatment Centers
Stanford Medical Center (Multidisciplinary Cutaneous Lymphoma Clinic)
Stanford, CA, United States
Treatment Centers
Oregon Health & Science University (OHSU)
Portland, OR, United States
Treatment Centers
Medical University of South Carolina
Charleston, SC, United States
Treatment Centers
John Hopkins Dermatology
Baltimore, MD, United States
Treatment Centers
OU Physicians
Oklahoma City, OK, United States
Treatment Centers
City of Hope National Medical Center
Duarte, CA, United States
Treatment Centers
Chao Family Comprehensive Cancer Center
Orange, CA, United States
Treatment Centers
Mayo Clinic - Florida
Jacksonville, FL, United States
Treatment Centers
Fondazione IRCCS Ca' Granda
Milan, Italy
Treatment Centers
IU Simon Cancer Center
Indianapolis, IN, United States
Treatment Centers
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Treatment Centers
Westmead Hospital - University of Sydney
Westmead, NSW, Australia
Treatment Centers
Medical University of Graz
Graz, Austria
Treatment Centers
Medical University of Vienna
Vienna, Austria
Treatment Centers
Hôtel-Dieu - CHU de Nantes
Nantes, France
Treatment Centers
Helsinki University Hospital
Helsinki, Finland
Treatment Centers
Hospital Dresden-Friedrichstadt
Dresden, Germany
Treatment Centers
Charité University of Medicine Berlin - Skin Cancer Center
Berlin, Germany
Treatment Centers
Skin Cancer Center - HELIOS Klinikum Krefeld
Krefeld, Germany
Treatment Centers
Rabin Medical Center
Petah-Tikva, Israel
Treatment Centers
Rambam Medical Center
Haifa, Israel
Treatment Centers
Spedali Civili di Brescia
Brescia, Italy
Treatment Centers
Cutaneous Lymphoma Multidisciplinary Clinic - Lisbon
Lisbon, Portugal
Treatment Centers
Friedrich Schiller University - Hospital Jena
Jena, Thuringia, Germany
Treatment Centers
University Medical Centre - Mannheim
Mannheim, Baden-Württemberg, Germany
Treatment Centers
University of Essen - Department of Dermatology
Essen, Germany
Treatment Centers
Semmelweis Medical School
Budapest, Hungary
Treatment Centers
Hospital Universitario 12 de Octubre
Madrid, Spain
Treatment Centers
University Hospital Zurich - Department of Dermatology
Zurich, Switzerland
Treatment Centers
Memorial Sloan Kettering Cancer Center
New York, NY, United States
Treatment Centers
John Theurer Cancer Center at HUMC
Hackensack, NJ, United States
Treatment Centers
Emil P. Bisaccia, MD, Center for Photopheresis at Morristown Medical Center
Morristown, NJ, United States
Treatment Centers
Johann Wolfgang Goethe-University Frankfurt
Frankfurt, Germany
Treatment Centers
OSU Comprehensive Cancer Center
Columbus, OH, United States
Treatment Centers
Roswell Park Comprehensive Cancer Center
Buffalo, NY, United States
Treatment Centers
St. Thomas Hospital - St Johns Department of Dermatology
London, United Kingdom
Clinical Trials
Lacutamab - TELLOMAK Study
An open label, multi-cohort, multi-center phase II study evaluating the efficacy and safety of lacutamab (IPH4102) alone or in combination with chemotherapy in patients with advanced t-cell lymphoma
Clinical Trial Name: IPH4102-201 / TELLOMAK study
Clinical Trial Description:
Clinical Trials
TTI-621 - Study
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Brief Summary
Multicenter, open-label, phase 1a/1b trial of TTI-621 in subjects with relapsed or refractory hematologic malignancies and selected solid tumors.
Clinical Trials
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB MF and SS
Brief Summary:
Clinical Trials
Pembrolizumab - Stage IB-IV Mycosis Fungoides
Brief Summary:
This phase II trial studies how well pembrolizumab works in treating patients with stage IB-IV mycosis fungoides. Antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread.
Website: https://clinicaltrials.gov/ct2/show/NCT03695471?term=mc1788&draw=2&rank=1
PRIMARY OBJECTIVE: